Optimization of monoclonal antibody expression in CHO cells by employing epigenetic gene regulation tools

Optimization of monoclonal antibody expression in CHO cells by employing epigenetic gene regulation tools

Monoclonal antibodies (mAbs) are crucial in pharmaceutical biotechnology. Mammalian cell lines are the most preferred for their production. One of the significant challenging issues of mammalian expression systems is epigenetic gene silencing. Employing epigenetic gene regulation tools can increase the productivity of the mammalian cell lines. Sodium butyrate (NaBut) and valproic acid (VPA) regulate gene expression by inhibiting histone deacetylase. A ubiquitous chromatin-opening element (UCOE) can improve expression by reducing DNA methylation. Here, the separate and combined effects of NaBut and VPA histone deacetylase inhibitors (iHDACs) and UCOE on mAb synthesis were studied. Stable cell lines were generated by non-UCOE (CHO-HL) and UCOE-containing vectors (CHO-UHUL) and cultured in the presence and absence of NaBut or VPA. Expression analysis showed that CHO-UHUL gave a 4-fold greater yield than non-UCOE CHO-HL. Antibody production levels of the CHO-HL and CHO-UHUL cells increased 2-fold and 2.5-fold after NaBut and VPA treatment, respectively. These results indicate that UCOE has more impact on antibody expression than iHDACs. iHDAC treatment exhibited at least a 0.5-fold higher antibody yield in UCOE containing CHO-UHUL cells. Thus utilization of NaBut and VPA (iHDACs) and UCOE resulted in antibody expression improvement, and the combined use of them had a synergistic effect on antibody synthesis.

___

  • Aggarwal S (2011). What’s fueling the biotech engine—2010 to 2011. Nat Biotechnol 29: 1083-1089.
  • Ahmadi M, Mahboudi F, Eidgahi A, Reza M, Nasr R, Nematpour F, Ahmadi S, Ebadat S, Aghaeepoor M, Davami F (2016). Evaluating the efficiency of phiC31 integrase‐mediated monoclonal antibody expression in CHO cells. Biotechnol Prog 32: 1570-1576.
  • Allen ML, Antoniou M (2007). Correlation of DNA methylation with histone modifications across the HNRPA2B1-CBX3 ubiquitously-acting chromatin open element (UCOE). Epigenetics 2: 227-236.
  • Antoniou M, Harland L, Mustoe T, Williams S, Holdstock J, Yague E, Mulcahy T, Griffiths M, Edwards S, Ioannou PA (2003). Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. Genomics 82: 269-279.
  • Backliwal G, Hildinger M, Kuettel I, Delegrange F, Hacker DL, Wurm FM (2008). Valproic acid: a viable alternative to sodium butyrate for enhancing protein expression in mammalian cell cultures. Biotechnol Bioeng 101: 182-189.
  • Benton T, Chen T, McEntee M, Fox B, King D, Crombie R, Thomas TC, Bebbington C (2002). The use of UCOE vectors in combination with a preadapted serum free, suspension cell line allows for rapid production of large quantities of protein. Cytotechnology 38: 43-46.
  • Boscolo S, Mion F, Licciulli M, Macor P, De Maso L, Brce M, Antoniou MN, Marzari R, Santoro C, Sblattero D (2012). Simple scale-up of recombinant antibody production using an UCOE containing vector. New Biotechnology 29: 477-484.
  • Davie JR (2003). Inhibition of histone deacetylase activity by butyrate. Journal Nutr 133: 2485S-2493S.
  • Ecker DM, Jones SD, Levine HL (2015). The therapeutic monoclonal antibody market. MAbs 7: 9-14.
  • Fukushige S, Sauer B (1992). Genomic targeting with a positiveselection lox integration vector allows highly reproducible gene expression in mammalian cells. Proc Natl Acad Sci U S A 89: 7905-7909.
  • Gilbertson L (2003). Cre–lox recombination: Cre-ative tools for plant biotechnology. Trends Biotechnol 21: 550-555.
  • Hong JK, Lee SM, Kim KY, Lee GM (2014). Effect of sodium butyrate on the assembly, charge variants, and galactosylation of antibody produced in recombinant Chinese hamster ovary cells. Applied Microbiology and Biotechnology 98: 5417-5425.
  • Jiang Z, Sharfstein ST (2008). Sodium butyrate stimulates monoclonal antibody over‐expression in CHO cells by improving gene accessibility. Biotechnol Bioeng 100: 189-194.
  • Kobayashi H, Tan EM, Fleming SE (2004). Acetylation of histones associated with the p21WAF1/CIP1 gene by butyrate is not sufficient for p21WAF1/CIP1 gene transcription in human colorectal adenocarcinoma cells. Int J Cancer 109: 207-213.
  • Kwaks TH, Otte AP (2006). Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells. Trends Biotechnol 24: 137-142.
  • Li J, Zhu Z (2010). Research and development of next generation of antibody-based therapeutics. Acta Pharmacologica Sinica 31: 1198-1207.
  • Mariani MR, Carpaneto EM, Ulivi M, Allfrey VG, Boffa LC (2003). Correlation between butyrate-induced histone hyperacetylation turn-over and c-myc expression. J Steroid Biochem Mol Biol 86: 167-171.
  • Nematpour F, Mahboudi F, Vaziri B, Khalaj V, Ahmadi S, Ahmadi M, Ebadat S, Davami F (2017). Evaluating the expression profile and stability of different UCOE containing vector combinations in mAb-producing CHO cells. BMC Biotechnol 17: 18.
  • Richards EJ, Elgin SC (2002). Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell 108: 489-500.
  • Rodrigues Goulart H, Arthuso FdS, Capone MVN, Oliveira TL, Bartolini P, Soares CRJ (2010). Enhancement of human prolactin synthesis by sodium butyrate addition to serum-free CHO cell culture. J Biomed Biotechnol 2010.
  • Sambrook J, Russell D (2001). Molecular Cloning. A Laboratory Manual. 3rd ed. 1: 1.32-1.34, Cold Spring Harbor, NY, USA: Laboratory Press.
  • Tennant JR (1964). Evaluation of the trypan blue technique for determination of cell viability. Transplantation 2: 685-694. Walsh G (2014). Biopharmaceutical benchmarks 2014. Nat Biotechnol 32: 992-1000.
  • Williams S, Mustoe T, Mulcahy T, Griffiths M, Simpson D, Antoniou M, Irvine A, Mountain A, Crombie R (2005). CpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells. BMC Biotechnol 5: 17.
  • Wilson C, Bellen HJ, Gehring WJ (1990). Position effects on eukaryotic gene expression. Annu Rev Cell Biol 6: 679-714.
  • Wippermann A, Rupp O, Brinkrolf K, Hoffrogge R, Noll T (2016). Integrative analysis of DNA methylation and gene expression in butyrate-treated CHO cells. J Biotechnol (in press).
  • Wurm FM (2004). Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22: 1393-1398.